P06493 |
CDK1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P06493 |
CDK1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P06493 |
CDK1_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P06493 |
CDK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P06493 |
CDK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06493 |
CDK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P06493 |
CDK1_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P06493 |
CDK1_HUMAN |
Transplant rejection [ICD-11: NE84] |
P06493 |
CDK1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P06493 |
CDK1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P49841 |
GSK3B_HUMAN |
Myotonic disorder [ICD-11: 8C71] |
P49841 |
GSK3B_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P49841 |
GSK3B_HUMAN |
Fragile X chromosome [ICD-11: LD55] |
P49841 |
GSK3B_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P49841 |
GSK3B_HUMAN |
Osteosarcoma [ICD-11: 2B51] |
P49841 |
GSK3B_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P49841 |
GSK3B_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P49841 |
GSK3B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P49841 |
GSK3B_HUMAN |
Brain cancer [ICD-11: 2A00] |
P49841 |
GSK3B_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P49841 |
GSK3B_HUMAN |
Transplant rejection [ICD-11: NE84] |
P49841 |
GSK3B_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P49841 |
GSK3B_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P49841 |
GSK3B_HUMAN |
Myotonic disorder [ICD-11: 8C71] |
P49841 |
GSK3B_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P49841 |
GSK3B_HUMAN |
Fragile X chromosome [ICD-11: LD55] |
P49841 |
GSK3B_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P49841 |
GSK3B_HUMAN |
Osteosarcoma [ICD-11: 2B51] |
P49841 |
GSK3B_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P49841 |
GSK3B_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P49841 |
GSK3B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P49841 |
GSK3B_HUMAN |
Brain cancer [ICD-11: 2A00] |
P49841 |
GSK3B_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P49841 |
GSK3B_HUMAN |
Transplant rejection [ICD-11: NE84] |
P49841 |
GSK3B_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P49841 |
GSK3B_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
Q00535 |
CDK5_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P49840 |
GSK3A_HUMAN |
Epilepsy/seizure [ICD-11: 8A61-8A6Z] |
P49840 |
GSK3A_HUMAN |
Substance abuse [ICD-11: 6C40] |
P49840 |
GSK3A_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P49840 |
GSK3A_HUMAN |
Fragile X chromosome [ICD-11: LD55] |
P49840 |
GSK3A_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P49840 |
GSK3A_HUMAN |
Brain cancer [ICD-11: 2A00] |
P49840 |
GSK3A_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P49840 |
GSK3A_HUMAN |
Transplant rejection [ICD-11: NE84] |